Morgan Stanley »

Rapt Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2025-06-30 $144k 18k 8.00

More positions owned by Morgan Stanley

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Ishares Tr Core S&p500 Etf (IVV)
Tesla Motors (TSLA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Morgan Stanley

Top funds holding Rapt Therapeutics

TCG Crossover Management
Foresite Capital Management VI
Rtw Investments
OrbiMed Advisors
Ikarian Capital
Boone Capital Management
Deep Track Capital
Vanguard Group
Nantahala Capital Management
Siren
Redmile Group
Soleus Capital Management
ADAR1 Capital Management
Fcpm Iii Services B.v.
Boothbay Fund Management

View all funds holding Rapt Therapeutics